Retatrutide 10mg
Triple Agonist
Triple agonist peptide targeting GLP-1, GIP, and glucagon receptors. Research-grade compound studied for metabolic and body composition applications. Stated purity ≥99%.
This category covers incretin receptor agonists, mitochondrial peptides, and metabolic coenzymes studied in the context of energy regulation, body composition, and cellular metabolism. Compounds include Retatrutide (a triple GLP-1/GIP/glucagon receptor agonist), Tirzepatide (a dual GLP-1/GIP agonist), MOTS-C (a mitochondria-derived mitokine implicated in mitochondrial stress signaling and metabolic homeostasis), NAD+ (a coenzyme central to cellular energy metabolism, sirtuins, and PARP-mediated DNA repair), SS-31 (a mitochondria-targeting tetrapeptide), and proprietary metabolic blends formulated for multi-target research protocols. Retatrutide and Tirzepatide are supplied as lyophilized powders in multiple lot sizes to accommodate both pilot-scale and extended in vitro studies. MOTS-C is a 16-amino acid peptide encoded within the mitochondrial 12S rRNA gene and has been studied in preclinical models for its effects on insulin sensitivity and exercise-induced metabolic adaptation. All compounds are supplied at a ≥99% purity target with lot-level HPLC documentation available on request. For laboratory research use only. Not for human or veterinary administration.
Triple Agonist
Triple agonist peptide targeting GLP-1, GIP, and glucagon receptors. Research-grade compound studied for metabolic and body composition applications. Stated purity ≥99%.
Triple Agonist
Triple agonist peptide targeting GLP-1, GIP, and glucagon receptors. Research-grade compound studied for metabolic and body composition applications. Stated purity ≥99%.
Triple Agonist
Triple agonist peptide targeting GLP-1, GIP, and glucagon receptors. Research-grade compound studied for metabolic and body composition applications. Stated purity ≥99%.
Triple Agonist
Triple agonist peptide targeting GLP-1, GIP, and glucagon receptors. Research-grade compound studied for metabolic and body composition applications. Stated purity ≥99%.
Dual GLP-1/GIP Agonist
Dual GLP-1/GIP receptor agonist peptide. Research compound studied for glucose regulation and metabolic function. Stated purity ≥99%; lot COA on request.
Dual GLP-1/GIP Agonist
Dual GLP-1/GIP receptor agonist peptide. Research compound studied for glucose regulation and metabolic function. Stated purity ≥99%; lot COA on request.
Peptide Blend
Proprietary peptide blend researched in metabolic and cellular energy models. 80mg total peptide content. Stated purity ≥99%.
Mitochondria-Targeting Peptide
SS-31 (Elamipretide) 50mg — mitochondria-targeting tetrapeptide. Stated purity ≥99%. For research use only.
RESEARCH USE ONLY: All products are intended for laboratory and research purposes only. Not for human consumption, diagnosis, treatment, or prevention of any disease.
Sealed Peptides sells research-use-only materials for laboratory use. You must be at least 21 years old to enter this site.
By entering you confirm that you will use all products for laboratory research only, not for human consumption.